NCT03754608View on ClinicalTrials.gov

Validating Imaging Biomarkers of Small Vessel Disease in Diabetic Individuals Using Advanced MRI Techniques.

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

November 7, 2018

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Small Vessel Disease of Diabetes Mellitus
Interventions
DIAGNOSTIC_TEST

MRI including cf-MRI, DTI, ASL and CVR.

A paradigm developed at Yale University called Cognitive Predictive Modelling which takes connectivity data and reduces it to two smaller network which predict higher and lower performance in a particular task for which these networks have been optimized. This will be supplemented by MRI vascular measures.

Trial Locations (1)

06510

Yale University School of Medicine, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT03754608 - Validating Imaging Biomarkers of Small Vessel Disease in Diabetic Individuals Using Advanced MRI Techniques. | Biotech Hunter | Biotech Hunter